International Journal of Clinical Biochemistry and Research

Print ISSN: 2394-6369

Online ISSN: 2394-6377

CODEN : IJCBK6

International Journal of Clinical Biochemistry and Research (IJCBR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...

Article type

Original Article


Article page

159- 163


Authors Details

Shylaja T.V., Asmabi Makandar, Raghavendra D.S., Patnaik A.N. , Shanthi Naidu


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 1378

PDF Downloaded: 539


The role of serum Cystatin C as early marker of acute kidney injury in subjects undergoing percutaneous transluminal coronary angiogram with normal serum creatinine levels


Original Article

Author Details : Shylaja T.V., Asmabi Makandar, Raghavendra D.S., Patnaik A.N. , Shanthi Naidu

Volume : 4, Issue : 2, Year : 2017

Article Page : 159-163


Suggest article by email

Get Permission

Abstract

Background: Despite more than half a century of investigations, Acute kidney injury (AKI) remains a major healthcare issue in medicine today, reported to occur in 1–32% of all hospital admissions and 10–90% of intensive care unit admissions and the diagnosis of AKI is usually based on changes in Serum Creatinine (SCr) which is a poor marker of early renal dysfunction.
Objectives: To study the role of Serum Cystatin C (CysC) as early marker of AKI and to correlate the Serum Cys C with conventional marker like SCr in early detection of Contrast induced acute kidney injury (CIAKI) in subjects undergoing Percutaneous transluminal coronary angiogram (PTCA).
Materials and Method: Prospective cohort study was conducted, where SCr and Serum CysC were serially measured in a heterogeneous group of subjects (n=60) presenting to cardiology department and the primary outcome was CIAKI.
Results: The study population consisted of 60 subjects. All subjects were divided into 2 groups: “CIAKI group” and “no-CIAKI group” according to predefined definition. The Serum Cys C increased at 4 hours and reached the peak at 24 hours, whereas SCr increased at 24 hours and reached peak at 48 hours respectively(P<0.001) and there was no significant correlation between Serum Cys C with SCr at 0 hours, 4 hours , 24 hours and 48 hours .
Conclusion: Serum CysC is an early marker for detecting CIAKI compare to conventional marker SCr. So earlier detection of CIAKI by this novel biomarker can reduce morbidity and mortality and also hospital stay.

Keywords: Serum Creatinine, Estimated glomerular filtration rate, Cystatin C, Percutaneous Trans luminal Coronary angiogram, Contrast induced acute kidney injury


How to cite : T.v. S, Makandar A, D.s. R, A.n. P, Naidu S, The role of serum Cystatin C as early marker of acute kidney injury in subjects undergoing percutaneous transluminal coronary angiogram with normal serum creatinine levels. Int J Clin Biochem Res 2017;4(2):159-163

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.